FDA Sets Target Date To Expand Dwarfism Care Voxzogo To Younger Children
Drug Topics
MARCH 9, 2023
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
Let's personalize your content